Loading...
ROCO
8935
Market cap59mUSD
Jul 09, Last price  
22.65TWD
1D
1.12%
1Q
16.15%
Jan 2017
322.57%
IPO
19.40%
Name

Pontex Polyblend Co Ltd

Chart & Performance

D1W1MN
ROCO:8935 chart
P/E
P/S
3.68
EPS
Div Yield, %
Shrs. gr., 5y
5.66%
Rev. gr., 5y
-13.34%
Revenues
518m
-6.33%
969,311,0001,060,094,0001,379,203,000946,483,000594,313,000553,239,000518,239,000
Net income
-87m
L+18.08%
25,062,000-23,041,00043,464,00027,356,000-69,898,000-73,343,000-86,600,000
CFO
26m
P
-47,413,00045,322,00039,295,000146,986,00079,506,000-4,014,00025,681,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Pontex Polyblend Co., Ltd., established in 1982 and headquartered in Taichung City, Taiwan, is a global enterprise specializing in two core areas: the production of engineering plastics compound materials and footwear manufacturing through injection molding. The company's operations span Taiwan, mainland China, the United States, and various international markets. Pontex Polyblend offers a wide array of plastic compound materials, including ABS, PC, nylon, PP, PBT, NPE, TPU, PLA, PBS, and r-PET. These advanced materials find diverse applications in sectors such as consumer electronics (3C), industrial machinery parts, automotive and motorcycle components, household consumer goods, sporting equipment and toys, and medical supplies. In its footwear division, the company manufactures various sports equipment components, such as outsoles for baseball, football, soccer, and bicycles. It also produces critical shoe components like midsoles, shanks, and counters, alongside complete sports footwear. Furthermore, Pontex Polyblend acts as an original equipment manufacturer (OEM), producing injection-molded women's shoe uppers for the well-known CROCS brand.
IPO date
Jan 02, 2002
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT